ProCE Banner Activity

TARA: Tapering csDMARDs First vs TNF Inhibitors in Patients With RA and Very Low Disease Activity

Slideset Download
Conference Coverage
Similar disease flare rates with both tapering schedules, but tapering csDMARD first associated with numerically higher DMARD-free remission.

Released: November 15, 2019

Expiration: November 13, 2020

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Mallinckrodt Pharmaceuticals